Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,221 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

NCT00514085

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Cross Cancer Institute Edmonton, Alberta, Canada

BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada

BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada

CancerCare Manitoba Winnipeg, Manitoba, Canada

View Trial Details

Completed

Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients With High-Risk Neuroblastoma and GD2-Positive Tumors

NCT01419834

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor

NCT00006734

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +8 more
Locations: Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States

University of South Alabama Cancer Research Institute Mobile, Alabama, United States

Phoenix Children's Hospital Phoenix, Arizona, United States

Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States

View all 239 locations

View Trial Details

Completed

Patient-led Surveillance Compared to Clinician-led Surveillance in People Treated for Localised Melanoma.

NCT03581188

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Newcastle Skin Check Newcastle, New South Wales, Australia

Melanoma Institute Australia North Sydney, New South Wales, Australia

Royal Prince Alfred Hospital Sydney, New South Wales, Australia

View Trial Details

Completed

Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers

NCT03538587

Conditions: Astrocytoma, Brain Cancer, Brain Diseases, +24 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560

NCT04351373

Conditions: Cranial Nerve Diseases, Cranial Nerve Neoplasms, Ear Diseases, +19 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Completed

Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors

NCT02988817

Conditions: Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +46 more
Locations: Mayo Clinic - Phoenix Phoenix, Arizona, United States

University of Colorado Hospital Aurora, Colorado, United States

Yale University, Smilow Cancer Center at Yale New Haven Hospital New Haven, Connecticut, United States

Mayo Clinic Jacksonville Jacksonville, Florida, United States

View all 41 locations

View Trial Details

Completed

Artificial Intelligence Augmented Training in Skin Cancer Diagnostics for General Practitioners

NCT04576416

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: AISC Research Fascility Valby, Danmark, Denmark

View Trial Details

Completed

New Strategies to Detect Cancers in Carriers of Mutations in RB1

NCT04164134

Conditions: Eye Diseases, Eye Diseases, Hereditary, Eye Neoplasms, +12 more
Locations: Institute Curie Paris, France

University Hospital Essen (UHE) Essen, Germany

Amsterdam UMC, location VUmc Amsterdam, Netherlands

View Trial Details

Completed

Phase II Trial of Extended-Dosing Temozolomide in Patients With Melanoma

NCT00591370

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions